Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.morningstar.com › stocks › XNASMRNS Stock Price Quote | Morningstar

    Hace 5 días · See the latest Marinus Pharmaceuticals Inc stock price (MRNS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

  2. Imágenes

    • Marinus Kraus gibt Karriereende bekannt - skispringen.com
    • Marinus Kraus - Alchetron, The Free Social Encyclopedia
    • Marinus Kraus German jumper ski jumping gold medal at the Olympic Games ...
    • Oberaudorf: Marinus Kraus wird Deutscher Meister im Skisprung

    Ver todo

  3. www.bloomberg.com › quote › MRNS:USMRNS: Marinus Pharmaceuticals Inc Stock Price Quote - NASDAQ GM -...

    Hace 3 días · Stock analysis for Marinus Pharmaceuticals Inc (MRNS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  4. www.marketscreener.com › quote › stockMRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals,...

    Hace 5 días · Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. The Company is engaged in the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus, which includes the use of ZTALMY (ganaxolone).

  5. Videos

    Ver todo

  6. www.marketbeat.com › stocks › NASDAQMarinus Pharmaceuticals (MRNS) Stock Price, News & Analysis -...

    Hace 4 días · Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders.

  7. stockanalysis.com › stocks › mrnsMarinus Pharmaceuticals, Inc. (MRNS) - Stock Analysis

    Hace 4 días · Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders.

  8. www.marketscreener.com › quote › stockMarinus Pharmaceuticals, Inc. Stock - MarketScreener.com

    Hace 3 días · Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. The Company is engaged in the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus, which includes the use of ZTALMY (ganaxolone).

  9. synapse.patsnap.com › article › marinus-pharmaceuticals-to-announce-q1-2024Marinus Pharmaceuticals to Announce Q1 2024 Results on May 8

    Hace 5 días · Marinus Pharmaceuticals, Inc., a company listed on Nasdaq under the ticker symbol MRNS, is devoted to developing cutting-edge treatments for seizure disorders. On May 8, 2024, before the market opens, Marinus plans to disclose its financial results for the first quarter ending March 31, 2024.